Vivani Medical Statistics
Total Valuation
Vivani Medical has a market cap or net worth of $89.46 million. The enterprise value is $101.28 million.
Important Dates
The next estimated earnings date is Thursday, November 13, 2025, before market open.
| Earnings Date | Nov 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Vivani Medical has 59.24 million shares outstanding. The number of shares has increased by 10.54% in one year.
| Current Share Class | 59.24M |
| Shares Outstanding | 59.24M |
| Shares Change (YoY) | +10.54% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 49.83% |
| Owned by Institutions (%) | 8.36% |
| Float | 23.46M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 18.22 |
| P/TBV Ratio | 18.22 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.30, with a Debt / Equity ratio of 3.79.
| Current Ratio | 1.30 |
| Quick Ratio | 1.09 |
| Debt / Equity | 3.79 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -177.75% and return on invested capital (ROIC) is -49.69%.
| Return on Equity (ROE) | -177.75% |
| Return on Assets (ROA) | -43.42% |
| Return on Invested Capital (ROIC) | -49.69% |
| Return on Capital Employed (ROCE) | -120.73% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$690,189 |
| Employee Count | 37 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +19.84% in the last 52 weeks. The beta is 3.29, so Vivani Medical's price volatility has been higher than the market average.
| Beta (5Y) | 3.29 |
| 52-Week Price Change | +19.84% |
| 50-Day Moving Average | 1.45 |
| 200-Day Moving Average | 1.25 |
| Relative Strength Index (RSI) | 48.36 |
| Average Volume (20 Days) | 543,316 |
Short Selling Information
The latest short interest is 243,281, so 0.41% of the outstanding shares have been sold short.
| Short Interest | 243,281 |
| Short Previous Month | 272,628 |
| Short % of Shares Out | 0.41% |
| Short % of Float | 1.04% |
| Short Ratio (days to cover) | 1.23 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -26.79M |
| Pretax Income | -25.54M |
| Net Income | -25.54M |
| EBITDA | -26.38M |
| EBIT | -26.79M |
| Earnings Per Share (EPS) | -$0.44 |
Full Income Statement Balance Sheet
The company has $6.79 million in cash and $18.62 million in debt, giving a net cash position of -$11.82 million or -$0.20 per share.
| Cash & Cash Equivalents | 6.79M |
| Total Debt | 18.62M |
| Net Cash | -11.82M |
| Net Cash Per Share | -$0.20 |
| Equity (Book Value) | 4.91M |
| Book Value Per Share | 0.08 |
| Working Capital | 2.00M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$22.72 million and capital expenditures -$413,000, giving a free cash flow of -$23.14 million.
| Operating Cash Flow | -22.72M |
| Capital Expenditures | -413,000 |
| Free Cash Flow | -23.14M |
| FCF Per Share | -$0.39 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Vivani Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.54% |
| Shareholder Yield | -10.54% |
| Earnings Yield | -28.55% |
| FCF Yield | -25.86% |
Analyst Forecast
The average price target for Vivani Medical is $4.00, which is 164.90% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $4.00 |
| Price Target Difference | 164.90% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |